Cervical cancer prevention by vaccination: Nurses' knowledge, attitudes and intentions

Journal of Advanced Nursing

Volumn 65, Issue 3, 2009, Pages 499-508

  Duval, Bernard ^a   Gilca, Vladimir ^a,b   Boulianne, Nicole ^a,c,d   Pielak, Karen ^e,f   Halperin, Beth ^g,h   Simpson, Mary Anne ⁱ   Sauvageau, Chantal ^a,b   Ouakki, Manale ^a,b   Dube, Eve ^a,b   Lavoie, France ^d  

^a Quebec National Public Health Institute   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c Research Group in Immunization

^d LAVAL UNIVERSITY   (Canada)

^e BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g Canadian Center for Vaccinology Dalhousie University Halifax   (Canada)

^h DALHOUSIE UNIVERSITY   (Canada)

ⁱ Vaccine Preventable Diseases Department   (Canada)

Author keywords

Attitudes; Cervical cancer; Human papillomavirus; Intentions; Knowledge; Nurses; Prevention; Vaccination

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; ATTITUDE TO HEALTH; CANADA; CANCER DIAGNOSIS; CHILD; CLINICAL TRIAL; FEMALE; HUMAN; MULTICENTER STUDY; NURSE; NURSING EDUCATION; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; UTERINE CERVIX CARCINOMA IN SITU; VACCINATION; VIRUS INFECTION;

ADOLESCENT; ADULT; CANADA; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHILD; EARLY DETECTION OF CANCER; EDUCATION, NURSING, CONTINUING; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; NURSES; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; QUESTIONNAIRES; VACCINATION; YOUNG ADULT;

EID: 59449095448     PISSN: 03092402     EISSN: 13652648     Source Type: Journal    
DOI: 10.1111/j.1365-2648.2008.04900.x     Document Type: Article

References (43)

1. Baden L.R., Curfman G.D., Morrissey S. Drazen J.M. (2007) Human papillomavirus vaccine - opportunity and challenge. The New England Journal of Medicine 356 (19 1990 1991.
2. Baseman J.G. Koutsky L.A. (2005) The epidemiology of human papillomavirus infections. Journal of Clinical Virology 32 (Suppl. 1 S16 S24.
3. Bory J. P., Cucherousset J., Lorenzato M., Gabriel R., Quereux C., Birembaut P. Clavel C. (2002) Recurrent human papillomavirus infection detected with the hybrid capture II assay selects women with normal cervical smears at risk for developing high grade cervical lesions: a longitudinal study of 3,091 women. International Journal of Cancer 102 (5 519 525.
4. Bosch X. Harper D. (2006) Prevention strategies of cervical cancer in the HPV vaccine era. Gynecologic Oncology 103 (1 21 24.
5. Brabin L., Roberts S.A., Farzaneh F. Kitchener H.C. (2006) Future acceptance of adolescent human papillomavirus vaccination: a survey of parental attitudes. Vaccine 24 (16 3087 3094.
6. Clifford G.M., Rana R.K., Franceschi S., Smith J.S., Gough G. Pimenta J.M. (2005) Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiology Biomarkers & Prevention 14 (5 1157 1164.
7. Comité sur l'immunisation du Québec (2005) L'infirmière et la vaccination: constats et recommandations. Québec, Institut national de santé publique du Québec. Retrieved from http://www.inspq.qc.ca/pdf/publications/480- InfirmiereEtVaccination.pdf on 21 November 2008.
8. Davis K., Dickman E., Ferris D. Dias J. (2004) Human papillomavirus vaccine acceptability among parents of 10 to 15 year old adolescents. Journal of Lower Genital Tract Disease 8 (3 188 194.
9. Dempsey A.F., Zimet G.D., Davis R.L. Koutsky L. (2006) Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics 117 (5 1486 1493.
10. Dillman D.A. (2000) Mail and Internet Surveys - The Tailored Design Method. John Wiley & Sons, New York.
11. Dobson S., Deeks S. Money D. (2007) Statement on human papillomavirus vaccine. Canada Communicable Disease Report 33, 32.
12. Duval B., Gilca V., McNeil S., Dobson S., Money D., Gemmill I.M. et al. (2007) Vaccination against human papillomavirus: a baseline survey of Canadian clinicians' knowledge, attitudes and beliefs. Vaccine 25 (45 7841 7847.
13. Erickson L.J., De Wals P. Farand L. (2005) An analytical framework for immunization programs in Canada. Vaccine 23 (19 2470 2476.
14. Esposito S., Bosis S., Pelucchi C., Begliatti E., Rognoni A., Bellasio M. et al. (2007) Pediatrician knowledge and attitudes regarding human papillomavirus disease and its prevention. Vaccine 25 (35 6437 6446.
15. Franco E.L., Cuzick J., Hildesheim A. de Sanjose S. (2006) Chapter 20: Issues in planning cervical cancer screening in the era of HPV vaccination. Vaccine 24 (Suppl. 3 S171 S177.
16. Friedman A.L. Shepeard H. (2008) Exploring the knowledge, attitudes, beliefs, and communication preferences of the general public regarding HPV: findings from CDC focus group research and implications for practice. Journal of Lower Genital Tract Disease 12 (2 151.
17. Gonik B. (2006) Strategies for fostering HPV vaccine acceptance. Infections Diseases in Obstetrics and Gynecology 14 (1 36797.
18. Gulli C. (2007) Our girls aren't guinea pigs. Maclean's Magazine, 27 Aug 2007, pp. 38 42. Retrieved from http://www.macleans.ca/science/health/article. jsp?content=20070827-108312-108312&page=1 on 21 November 2007.
19. Halperin S.A., Scheifele D., Duva l.B., Law B., Ward B., Bjornson G. et al. (2005) Canadian Association for Immunization Research and Evaluation (CAIRE) guidelines for industry-sponsored clinical trial and epidemiology contract research. Human Vaccines 1 (4 140 142.
20. Henderson Z., Irwin K.L., Montano D.E., Kasprzyk D., Carlin L., Greek A. et al. (2007) Anogenital warts knowledge and counseling practices of US clinicians: results from a national survey. Sexually Transmitted Diseases 34 (9 644 652.
21. Honish A., Loewen J. Perrin M. (2002) Injecting quality into your immunization program. Alberta RN 58 (4 6 8.
22. Hoover D.R., Carfioli B. Moench E.A. (2000) Attitudes of adolescentyoung adult women toward human papillomavirus vaccination and clinical trials. Health Care for Women International 21 (5 375 391.
23. Howard M., Koteles J., Lytwyn A., Elit L., Kaczorowski J. Randazzo J. (2007) Giving patients information on abnormal cytology and human papillomavirus: survey of health providers. European Journal of Gynaecological Oncology 28 (1 15 17.
24. Kahn J.A., Zimet G.D., Bernstein D.I., Riedesel J.M., Lan D., Huang B. et al. (2005) Pediatricians' intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes. Journal of Adolescent Health 37 (6 502 510.
25. Keam S.J. Harper D.M. (2008) Human Papillomavirus Types 16 and 18 Vaccine (Recombinant, AS04 Adjuvanted, Adsorbed) [Cervarixtrade mark]. Drugs 68 (3 359 372.
26. Kimman T.G., Boot H.J., Berbers G.A.M., Vermeer-de Bondt P.E., Ardine de Wit G. de Melker H.E. (2006) Developing a vaccination evaluation model to support evidence-based decision making on national immunization programs. Vaccine 24 (22 4769 4778.
27. Koch D., Thompson L. Swart B. (2005) Looking ahead to successful immunization programs. The Canadian Nurse 101 (2 14 15.
28. Lippman A., Melnychuk R., Shimmin C. Boscoe M. (2007) Human papillomavirus, vaccines and women's health: questions and cautions. Canadian Medical Association Journal 177 (5 484 487.
29. Mays R.M. Zimet G.D. (2004) Recommending STI vaccination to parents of adolescents: the attitudes of nurse practitioners. Sexually Transmitted Diseases 31 (7 428 432.
30. Nganwai P., Truadpon P., Inpa C., Sangpetngam B., Mekjarasnapa M., Apirakarn M. et al. (2008) Knowledge, attitudes and practices vis-a-vis cervical cancer among registered nurses at the Faculty of medicine, Khon Kaen University, Thailand. Asian Pacific Journal of Cancer Prevention 9 (1 15 18.
31. Olshen E., Woods E.R., Austin S.B., Luskin M. Bauchner H. (2005) Parental acceptance of the human papillomavirus vaccine. Journal of Adolescent Health 37 (3 248 251.
32. Parkin D.M. Bray F. (2006) Chapter 2: the burden of HPV-related cancers. Vaccine 24 (Suppl. 3 S11 S25.
33. Prislin R., Sawyer M.H., De Guire M., Brennan J., Holcomb K. Nader P.R. (2002) Missed opportunities to immunize - psychosocial and practice correlates. American Journal of Preventive Medicine 22 (3 165 169.
34. Raley J.C., Followwill K.A., Zimet G.D. Ault K.A. (2004) Gynecologists' attitudes regarding human papilloma virus vaccination: a survey of Fellows of the American College of Obstetricians and Gynecologists. Infectious Diseases of Obstetrics and Gynecology 12 (3-4 127 133.
35. Riedesel J.M., Rosenthal S.L., Zimet G.D., Bernstein D.I., Huang B., Lan D. et al. (2005) Attitudes about human papillomavirus vaccine among family physicians. Journal of Pediatric and Adolescent Gynecology 18 (6 391 398.
36. Saslow D., Castle P.E., Cox J.T., Davey D.D., Einstein M.H., Ferris D.G. et al. (2007) American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA: A Cancer Journal for Clinicians 57 (1 7 28.
37. Schiffman M., Herrero R., Desalle R., Hildesheim A., Wacholder S., Rodriguez A.C. et al. (2005) The carcinogenicity of human papillomavirus types reflects viral evolution. Virology 337 (1 76 84.
38. Taira A.V. (2004) Evaluating human papillomavirus vaccination programs. Emerging Infectious Diseases 10 (11 1915 1923.
39. Walsh J.M.E. McPhee S.J. (1992) A systems model of clinical preventive care: an analysis of factors influencing patient and physician. Health Education Quarterly 19 (2 157 175.
40. Wright T.C., Bosch F.X., Franco E.L., Cuzick J., Schiller J.T., Garnett G.P. et al. (2006) Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international experts. Vaccine 24 (Suppl. 3 S251 S261.
41. Yassi A., Murdzak C., Cheang M. Tran N. (1994) Influenza immunization: knowledge, attitude and behaviour of health care workers. Canadian Journal of Infection Control 9 (4 103 108.
42. Zimet G.D. (2005) Improving adolescent health: focus on HPV vaccine acceptance. Journal of Adolescent Health 37 (Suppl. 6 S17 S23.
43. Zimet G.D., Liddon N., Rosenthal S.L., Lazcano-Ponce E. Allen B. (2006) Chapter 24: psychosocial aspects of vaccine acceptability. Vaccine 24 (Suppl. 3 S201 S209.